In VivoCompany Changes ADAMS , Derek, PhD To: bluebird bio Inc. , Chief Technology & Mfg. Officer (March) From: Evelo Biosciences, SVP, CMC Phone: 339-499-9300 ARBET-ENGELS , Christophe, MD, PhD To:
In VivoNew At The Helm Company Changes ALLEN , Lee F., MD, PhD To: Argos Therapeutics Inc. , CMO (January) From: Spectrum Pharmaceuticals Inc., CMO Phone: 919-287-6300 ANSARI , Nick To: EnteroMedi
In VivoNew At The Helm Company Changes ALMEIDA , Joe To: Baxter International Inc. , Chmn. & CEO (Jan. 2016) From: Covidien PLC, Pres. & CEO Phone: 847-948-2000 AVILA , Manny To: IlluminOss Medica
ScripTakeda is ramping up its presence in oncology, having signed a deal with antibody-drug conjugate (ADC) specialist Mersana Therapeutics via subsidiary Millennium Pharmaceuticals. In an interview with